ArticleMethods in molecular biology (Clifton, N.J.)2026
Epitope Screening by Hydrogen-Deuterium Exchange Mass Spectrometry for Improved Immunotherapeutic Outcomes.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) is a powerful tool for mapping the interactions between antibodies and antigens. Automation, coupled with a suite of sophisticated enzymatic and analytical tools, has enabled HDX-MS epitope mapping of increasingly complex antigenic targets in screens of dozens of antibodies. When information about epitopes and allosteric changes from HDX-MS is considered in the context of binding and functional datasets, a deeper understanding of how antibodies achieve their therapeutic outcomes is achieved. These insights help guide the development of novel immunotherapeutics and vaccines. In this chapter, we discuss the key steps and considerations involved in designing and executing an HDX-MS epitope screening experiment.
Indexed as
Identifiers
41085634What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.